Company / Shareholders' Equity
Zimmer Biomet Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$12.7B
FY2025
5-year range
$12.0B / $12.7B
FY2021-FY2025
Trend
+1.8%
vs FY2024
Sector context
#14 of 161
Health Care
What the data says
Among 161 Health Care companies, Zimmer Biomet is in the top 9% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from $9.7B in FY2016 to $12.7B in FY2025.
Based on SEC 10-K filings.
$12.7B in FY2025 with a 5-year CAGR of +0.8%. Top quartile in the Health Care sector.
Remained stable around $12.7B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +1.8%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 161This company $12.7B Sector average $5.1B
▼
+150.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 1.8% year-over-year.
- Ranks #14 out of 161 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.7B | +1.8% |
| FY2024 | $12.5B | -0.1% |
| FY2023 | $12.5B | +3.8% |
| FY2022 | $12.0B | -5.1% |
| FY2021 | $12.7B | +3.8% |
| FY2020 | $12.2B | -1.6% |
| FY2019 | $12.4B | +9.9% |
| FY2018 | $11.3B | -4.0% |
| FY2017 | $11.7B | +21.4% |
| FY2016 | $9.7B | -2.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026